THE CALANDRA REPORT is a subscriber service by Thom Calandra.
Thom visits gold, silver, copper (and many other metals) producers and prospectors in jurisdictions worldwide. Thom is also on the line in special situations, among them pharmaceuticals, computer systems integrators; and select real estate and international market companies. Most are smaller than $500 million market worth.
Thom owns shares of about 52 publicly traded companies and publishes his portfolio for TCR subscribers. His top and currently favorite holdings include Abitibi Royalties, Angkor Gold, BioCryst Pharmaceuticals, Calibre Mining. They are all tradeable; few of them are in the news. They will be.
Go behind the subscriber wall to see it all. [None of these companies pays to advertise here; ‘your honor, this man has no ads,’ as Bill Murray might say.]
Thom’s original TCR in 2003 and 2004 was among the fastest growing financial newsletters in North America. So was his Thom Calandra’s StockWatch, which was free through 2004 from 1996 and reached an audited 50 million-plus “views” monthly.
Thom’s work appeared or appears on MarketWatch.com, Stockhouse, SmallCapPower.com, CEO.ca, in newspapers and magazines — and in private reports for consulting clients.
Thom’s work is first-hand reporting and sparks interest in companies, themes and commodities from large and individual investors.
The price of TCR currently is $139 yearly. The service offers original reporting and access to Thom’s personal and professional networks. It includes windows into profit opportunities in special situations, metals, gems, biomedicals and real estate.